Oncology

Figure 1 shows the study design [14]. Firstly, we estimated the effect of BMI and WHR on 856 plasma metabolites using MR. Secondly, we estimated the e...

Study design This was a single-centre, prospective descriptive study of bile samples collected by ERCP from patients with CCA or benign disease. All p...

Study population and clinical data collection This study retrospectively included 15 advanced-stage non-uveal melanoma patients (stage IV) who receive...

Maris JM, Hogarty MD, Bagatell R, Cohn SL. Neuroblastoma. Lancet. 2007;369:2106–20. Smith EI, Haase GM, Seeger RC, Brodeur GM. A surgical perspective...

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribut...

During a conversation with CancerNetwork®, Nicholas James Hornstein, MD, PhD, discussed results from the phase 2 INTERCEPT-TT trial (NCT05343013) that...

Outpatient step-up dosing of bispecific antibody therapy in multiple myeloma has been shown to be feasible in several academic centers and recent clin...

In a recent episode of the Oncology-on-the-Go podcast in collaboration with the American Psychosocial Oncology Society (APOS), host Daniel C. McFarlan...

In the phase 2 INTERCEPT-TT trial (NCT05343013), TAS-102 demonstrated improved levels of circulating tumor DNA (ctDNA) clearance vs a synthetic contro...

As part of a collaboration between CancerNetwork® and KidneyCAN, Michael B. Atkins, MD, spoke about novel biomarkers that may play a role in the detec...